Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NK cell lectin like receptor subfamily K member 1, also known as NKG2D, is an activating and costimulatory receptor expressed on NK cells, γδ T cells, and CD8+ αβ T cells. It recognizes stress-induced ligands like MICA, MICB, and ULBP family members on target cells, triggering cytotoxic responses against infected or malignant cells. It plays a critical role in immunosurveillance and innate immunity, bridging to adaptive immune regulation. The receptor forms a homodimer and associates with the DAP10 adaptor protein for signal transduction. In mice, alternative splicing leads to two isoforms that bind either DAP10 or both DAP10 and DAP12.
Agonist or antagonist of KLRK1 receptor signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NK cell lectin like receptor subfamily K member 1 (NKG2D).